US president has pitched initiative as populist assault on pharmaceutical firms, however analysts query if costs shall be inexpensive for many individuals.
Printed On 6 Feb 2026
United States President Donald Trump has launched a brand new web site that he says will decrease the price of prescription medicines, which have lengthy stood out for his or her sky-high costs within the US in contrast with related merchandise around the globe.
Trump introduced the launch of the brand new web site known as TrumpRx, which permits shoppers to purchase discounted medicine straight from pharma firms, at an occasion on the White Home on Thursday.
Beneficial Tales
listing of three objectsfinish of listing
“Individuals are going to save lots of some huge cash and be wholesome,” Trump mentioned, stating that a number of the world’s largest drug producers have agreed to carry down costs underneath “Most Favoured Nation” agreements in change for avoiding US tariffs.
The web site is launching with financial savings on greater than 40 in style medicine, the White Home mentioned.
Customers can search the positioning for the remedy they need, then print out a coupon and current it at a pharmacy to purchase on the discounted worth.
The Trump administration has pitched the initiative as a populist assault on highly effective pharmaceutical firms amid rising discontent over the state of the financial system.
A gaggle of 16 drug firms have agreed to low cost offers, underneath which they may supply decrease costs for sure medicine to authorities programmes equivalent to Medicaid and, by way of TrumpRx, to US shoppers.
The TrumpRx web site, which guarantees “the world’s lowest costs on prescribed drugs”, showcases greater than 40 drugs, together with weight-loss medicine equivalent to Ozempic and Wegovy, and calls the hassle “essentially the most impactful prescription worth reset within the historical past of our nation”.
“Due to President Trump, the times of Massive Pharma price-gouging are over,” the web site states.
However analysts have questioned whether or not the hassle will substantively deal with US drug costs or shake up the pharmaceutical business.
“There’s a actual query concerning the worth of this for folks with insurance coverage,” Juliette Cubanski, deputy director for Medicare coverage at well being coverage organisation KFF, informed the information company Reuters.
“In some circumstances, we might be out-of-pocket prices which can be nonetheless comparatively unaffordable for lots of people,” Cubanski mentioned.
TrumpRx is consultant of the US president’s personalistic fashion of shaping coverage, looking for to chop individual deals to advance his personal priorities slightly than utilizing conventional regulatory and legislative means.
A earlier evaluation by KFF acknowledged that the small print of the Most Favoured Nation agreements with the corporations “stay confidential, which implies that little or no is understood publicly about what precisely has been agreed to”.
Pharmaceutical firms stay a robust drive in US politics, with the watchdog group Open Secrets reporting that pharmaceutical producers spent a record-high $187m on lobbying actions in 2025.
